Home / XPO7 Knockout Cell Lines

XPO7 Knockout Cell Lines

Gene: XPO7

Official Full Name: exportin 7provided by HGNC

Gene Summary: The transport of protein and large RNAs through the nuclear pore complexes (NPC) is an energy-dependent and regulated process. The import of proteins with a nuclear localization signal (NLS) is accomplished by recognition of one or more clusters of basic amino acids by the importin-alpha/beta complex; see MIM 600685 and MIM 602738. The small GTPase RAN (MIM 601179) plays a key role in NLS-dependent protein import. RAN-binding protein-16 is a member of the importin-beta superfamily of nuclear transport receptors.[supplied by OMIM, Jul 2002]

Get A Quote
Products Background

Products

Catalog Number Product Name Species Gene Passage ratio Mycoplasma testing Price
KO30000 XPO7 Knockout cell line (HeLa) Human XPO7 1:3~1:6 Negative Online Inquiry
KO30001 XPO7 Knockout cell line (HCT 116) Human XPO7 1:2~1:4 Negative Online Inquiry
KO30002 XPO7 Knockout cell line (HEK293) Human XPO7 1:3~1:6 Negative Online Inquiry
KO30003 XPO7 Knockout cell line (A549) Human XPO7 1:3~1:4 Negative Online Inquiry

Background

XPO7 Gene Knockout Cell Lines are genetically engineered cellular models that have been created to study the role of the XPO7 (Exportin 7) gene in various biological processes. By employing CRISPR-Cas9 technology, these cell lines exhibit a complete knockout of the XPO7 gene, allowing researchers to investigate its functional significance in nuclear-cytoplasmic transport, cell cycle regulation, and cellular response to stressors.

The key function of XPO7 lies in its role as an export receptor for RNA and proteins, facilitating their transport out of the nucleus. By disrupting XPO7, researchers can elucidate compensatory pathways and downstream effects that arise in cellular mechanisms due to impaired nuclear export. This cellular model is critical for understanding diseases related to dysregulated nuclear transport, including certain cancers and neurodegenerative disorders, where XPO7 function may be altered.

In clinical and research settings, XPO7 Gene Knockout Cell Lines provide a powerful platform for drug development, gene therapy investigations, and basic biological research. These models empower scientists to visualize and characterize phenotypic changes in response to potential therapeutic agents, thus enabling the screening of drugs that may target the pathways influenced by XPO7.

The advantages of using XPO7 Gene Knockout Cell Lines over other traditional methods, such as overexpression systems or RNA interference, include the elimination of confounding factors associated with partial gene activity, ensuring that observed effects are due solely to the loss of XPO7 function. This specificity enhances experimental reliability and reproducibility, making it a preferred choice for high-throughput screening and detailed mechanistic studies.

Ultimately, XPO7 Gene Knockout Cell Lines represent a valuable asset for both researchers and clinicians looking to deepen their understanding of nuclear transport mechanisms. Our company specializes in providing high-quality, innovative biological products that support advances in medical research. With our expertise, we strive to equip scientists with the tools necessary to break new ground in their fields.

Please note that all services are for research use only. Not intended for any clinical use.

Get a free quote

If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.

0

There is no product in your cart.